share_log

HC Wainwright & Co. Reiterates Buy on Co-Diagnostics, Maintains $6 Price Target

HC Wainwright & Co. Reiterates Buy on Co-Diagnostics, Maintains $6 Price Target

HC Wainwright & Co.重申对Co-Diagnostics的买入,维持6美元的目标价
Benzinga ·  2023/02/23 06:14

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) with a Buy and maintains $6 price target.

HC Wainwright&Co.分析师陈毅重申联合诊断公司(CoDX)对买入的看法,并维持6美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发